ARCHIVES

New Drug for Lymphoma Enters Phase II Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 5 | May 28, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Shingleton To Head AACI; Saunders To Get Two More Jobs At U. Texas Medical Branch

January 21, 1977

Clearinghouse Says In Business

January 26, 1979

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991

Announcement, RFA On Drug Discovery Groups Coming

December 10, 1982

NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office.

September 23, 2005